Granting of European Patent July 14, 2018 “Pharmaceutical formulations and methods for oral delivery of biologically active ingredients” – This patent is granted covering Great Britain, France, Germany and Italy.
Breakthrough in children’s vaccines by oral delivery of vaccines such as TT and Diphtheria vaccines - TrabiORALTM, Transgene’s oral delivery platform has demonstrated excellent antibody response to Tetanus Toxoid delivered orally.
Granting of USA Patent October 20, 2015 “Adeno-Associated Virus 2/8 Micro RNA – 101 Therapy for Liver cancer”
July 3, 2017 – Transgene has sold some unused assets of the company, subsequent to shareholders’ approval and cleared the debt owing to Union Bank of India and No Dues Certificate has been received to that effect.
